🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 10 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 29,42 29,62 28,70 29,29 -0,41% 3,13% 328.000
15/03/2024 29,02 29,68 28,82 29,41 +0,51% 2,96% 1.256.400
14/03/2024 30,27 30,27 29,11 29,26 -3,40% 3,83% 445.700
13/03/2024 30,57 30,95 29,89 30,29 -0,88% 3,47% 370.000
12/03/2024 31,11 31,46 30,51 30,56 -1,48% 3,05% 260.200
11/03/2024 30,98 31,45 30,83 31,02 -1,24% 2,00% 444.100
08/03/2024 30,66 31,43 30,34 31,41 +2,51% 3,56% 527.900
07/03/2024 30,40 31,47 30,25 30,64 +1,76% 4,01% 626.700
06/03/2024 29,50 30,16 28,96 30,11 +2,28% 4,07% 605.400
05/03/2024 29,14 29,45 28,62 29,44 +0,82% 2,85% 452.600
04/03/2024 28,40 29,50 27,89 29,20 +1,18% 5,67% 711.600
01/03/2024 29,69 30,01 28,68 28,86 -2,89% 4,48% 662.200
29/02/2024 29,45 30,52 28,61 29,72 -0,64% 6,49% 768.400
28/02/2024 29,57 30,26 29,30 29,91 +0,20% 3,25% 540.700
27/02/2024 30,16 30,20 29,67 29,85 +0,37% 1,76% 497.600
26/02/2024 29,97 30,32 29,56 29,74 -1,00% 2,54% 351.700
23/02/2024 30,00 30,34 29,46 30,04 +0,23% 2,93% 348.500
22/02/2024 29,75 29,98 29,35 29,97 +0,91% 2,12% 358.300
21/02/2024 29,82 29,96 29,52 29,70 -0,54% 1,48% 299.900
20/02/2024 28,86 29,88 28,86 29,86 +2,68% 3,53% 401.500
16/02/2024 29,64 29,81 29,08 29,08 -1,96% 2,46% 350.000
15/02/2024 29,45 29,93 29,37 29,66 +1,47% 1,90% 286.800
14/02/2024 29,59 29,65 29,00 29,23 +0,07% 2,20% 286.700
13/02/2024 29,16 29,91 28,94 29,21 -2,70% 3,33% 360.700
12/02/2024 28,92 30,04 28,92 30,02 +4,31% 3,87% 644.700
09/02/2024 27,75 28,97 27,65 28,78 +3,90% 4,76% 604.000
08/02/2024 28,55 28,87 27,37 27,70 -2,77% 5,25% 1.319.200
07/02/2024 30,14 30,15 28,45 28,49 -7,44% 5,64% 1.045.000
06/02/2024 31,12 31,17 30,55 30,78 -1,16% 1,99% 501.200
05/02/2024 30,08 31,48 29,98 31,14 +2,64% 4,99% 633.600